Drug Rulings Clarify Pricing Test And Penalty Reviews

This summer has marked a watershed for two of the longest-running sagas in U.K. competition law. On June 19, the Court of Appeal handed down judgment in Pfizer Inc. and another v. Competition and Markets...

Already a subscriber? Click here to view full article